المؤلفون: Shabaneh TB; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States., Moffett HF; Outpace Bio, Inc., Seattle, WA, United States., Stull SM; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States., Derezes T; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States., Tait LJ; Outpace Bio, Inc., Seattle, WA, United States., Park S; Lyell Immunopharma, Inc., Seattle, WA, United States., Riddell SR; Immunotherapy Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States., Lajoie MJ; Outpace Bio, Inc., Seattle, WA, United States.

المصدر: Frontiers in molecular medicine [Front Mol Med] 2022 Oct 11; Vol. 2, pp. 1026474. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918402378306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2674-0095 (Electronic) Linking ISSN: 26740095 NLM ISO Abbreviation: Front Mol Med Subsets: PubMed not MEDLINE